germinal centers, and epithelial cells in intestinal crypts, so as to maintain a constant number (homeostasis). Elimination of potentially harmful self-reactive lymphocytes, either before or after they have completed their maturation, so as to prevent reactions against one's own tissues Death of host cells that have served their useful purpose, such as neutrophils in an acute inflammatory response, and lymphocytes at the end of an immune response. In these situations cells undergo apoptosis because they are deprived of necessary survival signals, such as growth factors
Apoptosis in Pathologic Conditions

Apoptosis eliminates cells that are injured beyond repair without eliciting a host reaction, thus limiting collateral tissue damage. Death by apoptosis is responsible for loss of cells in a variety of pathologic states:
DNA damage. Radiation, cytotoxic anticancer drugs, and hypoxia can damage DNA, either directly or via production of free radicals. If repair mechanisms cannot cope with the injury, the cell triggers intrinsic mechanisms that induce apoptosis. In these situations elimination of the cell may be a better alternative than risking mutations in the damaged DNA, which may result in malignant transformation. These injurious stimuli can cause apoptosis if the insult is mild, but larger doses of the same stimuli may result in necrotic cell death Accumulation of misfolded proteins. Improperly folded proteins may arise because of mutations in the genes encoding these proteins or because of extrinsic factors, such as damage caused by free radicals. Excessive accumulation of these proteins in the ER leads to a condition called ER stress, which culminates in apoptotic cell death. Apoptosis caused by the accumulation of misfolded proteins has been invoked as the basis of several degenerative diseases of the central nervous system and other organs.
Cell death in certain infections, particularly viral infections, in which loss of infected cells is largely due to apoptosis that may be induced by the virus (as in adenovirus and HIV infections) or by the host immune response (as in viral hepatitis). An important host response to viruses consists of cytotoxic T lymphocytes specific for viral proteins, which induce apoptosis of infected cells in an attempt to eliminate reservoirs of infection. During this process there can be significant tissue damage. The same T-cell-mediated mechanism is responsible for cell death in tumors and cellular rejection of transplants.
MORPHOLOGIC AND BIOCHEMICAL CHANGES IN APOPTOSIS
Before discussing the mechanisms of apoptosis, we describe the morphologic and biochemical characteristics of this process.
Morphology.
The following morphologic features, some best seen with the electron microscope, characterize cells undergoing apoptosis.
Cell shrinkage. The cell is smaller in size; the cytoplasm is dense; and the organelles, though relatively normal, are more tightly packed. (Recall that in other forms of cell injury, an early feature is cell swelling, not shrinkage.)
Chromatin condensation. This is the most characteristic feature of apoptosis. The chromatin aggregates peripherally, under the nuclear membrane, into dense masses of various shapes and sizes. The nucleus itself may break up, producing two or more fragments.
Formation of cytoplasmic blebs and apoptotic bodies. The apoptotic cell first shows extensive surface blebbing, then undergoes fragmentation into membranebound apoptotic bodies composed of cytoplasm and tightly packed organelles, with or without nuclear fragments.
Phagocytosis of apoptotic cells or cell bodies, usually by macrophages.
The apoptotic bodies are rapidly ingested by phagocytes and degraded by the phagocyte's lysosomal enzymes.
Plasma membranes are thought to remain intact during apoptosis, until the last stages, when they become permeable to normally retained solutes. This classical description is accurate with respect to apoptosis during physiologic conditions such as embryogenesis and deletion of immune cells. However, forms of cell death with features of necrosis as well as of apoptosis are not uncommon after many injurious stimuli. [39] Under such conditions the severity rather than the nature of the stimulus determines the pathway of cell death, necrosis being the major pathway when there is advanced ATP depletion and membrane damage.
On histologic examination, in tissues stained with hematoxylin and eosin, the apoptotic cell appears as a round or oval mass of intensely eosinophilic cytoplasm with fragments of dense nuclear chromatin. Because the cell shrinkage and formation of apoptotic bodies are rapid and the pieces are quickly phagocytosed, considerable apoptosis may occur in tissues before it becomes apparent in histologic sections. In addition, apoptosis-in contrast to necrosis-does not elicit inflammation, making it more difficult to detect histologically. 
Biochemical Features of Apoptosis
Apoptotic cells usually exhibit a distinctive constellation of biochemical alterations that underlie the structural changes described above.
Activation of Caspases.
A specific feature of apoptosis is the activation of several members of a family of cysteine proteases named caspases. [40] The term caspase is based on two properties of this family of enzymes: the "c" refers to a cysteine protease (i.e., an enzyme with cysteine in its active site), and "aspase" refers to the unique ability of these enzymes to cleave after aspartic acid residues. The caspase family, now including more than 10 members, can be divided functionally into two groups-initiator and executionerdepending on the order in which they are activated during apoptosis. Initiator caspases include caspase-8 and caspase-9. Several other caspases, including caspase-3 and caspase-6, serve as executioners. Like many proteases, caspases exist as inactive proenzymes, or zymogens, and must undergo an enzymatic cleavage to become active. The presence of cleaved, active caspases is a marker for cells undergoing apoptosis. We will discuss the roles of these enzymes in apoptosis later in this section.
DNA and Protein Breakdown.
Apoptotic cells exhibit a characteristic breakdown of DNA into large 50-to 300-kilobase pieces. [41] Subsequently, there is cleavage of DNA by Ca 2+ -and Mg 2+ -dependent endonucleases into fragments whose sizes are multiples of 180 to 200 base pairs, reflecting cleavage between nucleosomal subunits. The fragments may be visualized by electrophoresis as DNA "ladders" (Fig. 1-23) . Endonuclease activity also forms the basis for detecting cell death by cytochemical techniques that recognize double-stranded breaks of DNA. [41] A "smeared" pattern of DNA fragmentation is thought to be indicative of necrosis, but this may be a late autolytic phenomenon, and typical DNA ladders are sometimes seen in necrotic cells as well. 
Membrane Alterations and Recognition by Phagocytes.
The plasma membrane of apoptotic cells changes in ways that promote the recognition of the dead cells by phagocytes. One of these changes is the movement of some phospholipids (notably phosphatidylserine) from the inner leaflet to the outer leaflet of the membrane, where they are recognized by a number of receptors on phagocytes. These lipids are also detectable by binding of a protein called annexin V; thus, annexin V staining is commonly used to identify apoptotic cells. The clearance of apoptotic cells by phagocytes is described later.
CLINICO-PATHOLOGIC CORRELATIONS: APOPTOSIS IN HEALTH AND DISEASE
Examples of Apoptosis
Cell death in many situations is known to be caused by apoptosis, and the selected examples listed below illustrate the role of this death pathway in normal physiology and in disease. [54] Growth Factor Deprivation.
Hormone-sensitive cells deprived of the relevant hormone, lymphocytes that are not stimulated by antigens and cytokines, and neurons deprived of nerve growth factor die by apoptosis. In all these situations, apoptosis is triggered by the intrinsic (mitochondrial) pathway and is attributable to decreased synthesis of Bcl-2 and Bcl-x and activation of Bim and other pro-apoptotic members of the Bcl family.
DNA Damage.
Exposure of cells to radiation or chemotherapeutic agents induces apoptosis by a mechanism that is initiated by DNA damage (genotoxic stress) and that involves the tumor-suppressor gene p53. [55] p53 protein accumulates in cells when DNA is damaged, and it arrests the cell cycle (at the G 1 phase) to allow time for repair. However, if the damage is too great to be repaired successfully, p53 triggers apoptosis. When p53 is mutated or absent (as it is in certain cancers), it is incapable of inducing apoptosis, so that cells with damaged DNA are allowed to survive. In such cells the DNA damage may result in mutations or translocations that lead to neoplastic transformation. Thus, p53 serves as a critical "life or death" switch following genotoxic stress. The mechanism by which p53 triggers the distal death effector machinery-the caspases-is complex but seems to involve its function in transcriptional activation. Among the proteins whose production is stimulated by p53 are several pro-apoptotic members of the Bcl family, notably Bax, Bak, and some BH3-only proteins, mentioned earlier.
Protein Misfolding.
Chaperones in the ER control the proper folding of newly synthesized proteins, and misfolded polypeptides are ubiquitinated and targeted for proteolysis in proteasomes. If, however, unfolded or misfolded proteins accumulate in the ER, because of inherited mutations or stresses, they trigger a number of cellular responses, collectively called the unfolded protein response. [56,][57] This unfolded protein response activates signaling pathways that increase the production of chaperones, enhance proteasomal degradation of abnormal proteins, and slow protein translation, thus reducing the load of misfolded proteins in the cell (Fig. 1-27 ). However, if this cytoprotective response is unable to cope with the accumulation of misfolded proteins, the cell activates caspases and induces apoptosis. [58] [59] [60] This process is called ER stress. Intracellular accumulation of abnormally folded proteins, caused by genetic mutations, aging, or unknown environmental factors, is now recognized as a feature of a number of neurodegenerative diseases, including Alzheimer, Huntington, and Parkinson diseases (Chapter 28), and possibly type 2 diabetes. [61] Deprivation of glucose and oxygen, and stress such as heat, also result in protein misfolding, culminating in cell injury and death. FasL on T cells binds to Fas on the same or neighboring lymphocytes. This interaction plays a role in the elimination of lymphocytes that recognize self-antigens, and mutations affecting Fas or FasL result in autoimmune diseases in humans and mice. [62] The cytokine TNF is an important mediator of the inflammatory reaction, but it is also capable of inducing apoptosis. (The name "tumor necrosis factor" arose not because the cytokine kills tumor cells directly but because it induces thrombosis of tumor blood vessels, resulting in ischemic death of the tumor.) TNF-mediated death is readily demonstrated in cell cultures, but its physiologic or pathologic significance in vivo is not known. In fact, the major physiologic functions of TNF are mediated not by inducing apoptosis but by activating the important transcription factor NF-κB (nuclear factor-κB), which promotes cell survival by stimulating synthesis of anti-apoptotic members of the Bcl-2 family and, as we shall see in Chapter 2, activates a number of inflammatory responses. Since TNF can induce cell death and promote cell survival, what determines this yin and yang of its action? The answer is unclear, but it probably depends on which signaling proteins attach to the TNF receptor after binding of the cytokine.
Cytotoxic T Lymphocyte-Mediated Apoptosis.
Cytotoxic T lymphocytes (CTLs) recognize foreign antigens presented on the surface of infected host cells. Upon activation, CTLs secrete perforin, a transmembrane poreforming molecule, which promotes entry of the CTL granule serine proteases called granzymes. Granzymes have the ability to cleave proteins at aspartate residues and thus activate a variety of cellular caspases. [63] In this way the CTL kills target cells by directly inducing the effector phase of apoptosis. CTLs also express FasL on their surface and may kill target cells by ligation of Fas receptors.
Disorders Associated with Dysregulated Apoptosis
Dysregulated apoptosis ("too little or too much") has been postulated to explain aspects of a wide range of diseases. [56] Disorders associated with defective apoptosis and increased cell survival. An inappropriately low rate of apoptosis may permit the survival of abnormal cells, which may have a variety of consequences. For instance, if cells that carry mutations in p53 are subjected to DNA damage, the cells not only fail to die but are susceptible to the accumulation of mutations because of defective DNA repair, and these abnormalities can give rise to cancer. The importance of apoptosis in preventing cancer development is emphasized by the fact that mutation of p53 is the most common genetic abnormality found in human cancers. In other situations defective apoptosis results in failure to eliminate potentially harmful cells, such as lymphocytes that can react against selfantigens, and failure to eliminate dead cells, a potential source of self-antigens. Thus, defective apoptosis may be the basis of autoimmune disorders.
Disorders associated with increased apoptosis and excessive cell death. These diseases are characterized by a loss of cells and include (1) neurodegenerative diseases, manifested by loss of specific sets of neurons, in which apoptosis is caused by mutations and misfolded proteins; (2) ischemic injury, as in myocardial infarction and stroke; and (3) death of virus-infected cells, in many viral infections.
